Casi DeYoung
Vermögen: 509 951 $ am 30.06.2026
Vermögen: 509 951 $ am 30.06.2026
Casi DeYoung is currently Chief Business Officer at Shattuck Labs, Inc. since 2019.
Former roles include Operations Director-Oncology at Merck KGaA, Operations Director-Oncology at EMD Pharmaceuticals, Inc. from 2000 to 2005, Consulting Manager at Accenture Ltd., Vice President-Business Development at Reata Pharmaceuticals, Inc. from 2008 to 2013, Vice President-Business Development at ODC Therapy, Inc. from 2005 to 2008, Chief Business Officer at Mirna Therapeutics, Inc. from 2014 to 2017, and Chief Operating Officer & Vice President at ImmuneSensor Therapeutics, Inc. from 2018 to 2019.
Education includes undergraduate studies at Southwestern University and an MBA from McCombs School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SHATTUCK LABS, INC. 0.08% | 25.01.2026 | 73’480 ( 0.08% ) | 509 951 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SHATTUCK LABS, INC. | Corporate Officer/Principal | 01.12.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
ImmuneSensor Therapeutics, Inc.
ImmuneSensor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Geschäftsführer | 01.12.2019 |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Public Communications Contact | 01.06.2017 |
| REATA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2013 |
ODC Therapy, Inc.
ODC Therapy, Inc. Medical/Nursing ServicesHealth Services Operates offices of physical, occupational and speech therapists and audiologists | Corporate Officer/Principal | 01.03.2008 |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Corporate Officer/Principal | 01.01.2005 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Accenture Ltd.
Accenture Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting, technology & outsourcing services | Commercial Services |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
ODC Therapy, Inc.
ODC Therapy, Inc. Medical/Nursing ServicesHealth Services Operates offices of physical, occupational and speech therapists and audiologists | Health Services |
Southwestern University
Southwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
McCombs School of Business
McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shattuck Labs, Inc.
Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
ImmuneSensor Therapeutics, Inc.
ImmuneSensor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen